Previous studies found that an increase in CX3CL1-CX3CR1 in tumor is associated with the forming of anti-cancer NK cells and CD8+T cells in tumor, which improves the prognosis for patients with gastric adenocarcinoma and glioma (34, 35). This evidence concerns the gene CX3CL1 and cancer.